Meag Munich Ergo’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.7M | Sell |
140,686
-21,777
| -13% | -$8.76M | 1.54% | 24 |
|
|
2025
Q1 | $70.7M | Buy |
162,463
+23,453
| +17% | +$9.41M | 2.08% | 10 |
|
|
2024
Q4 | $51.3M | Buy |
139,010
+133,050
| +2,232% | +$55.7M | 1.62% | 25 |
|
|
2024
Q3 | $3.1M | Sell |
5,960
-3,934
| -40% | -$2.1M | 0.1% | 99 |
|
|
2024
Q2 | $5.36M | Sell |
9,894
-2,012
| -17% | -$1.06M | 0.18% | 83 |
|
|
2024
Q1 | $6.17M | Sell |
11,906
-6,681
| -36% | -$3.32M | 0.22% | 74 |
|
|
2023
Q4 | $8.76M | Buy |
18,587
+18,121
| +3,889% | +$8.38M | 0.33% | 62 |
|
|
2023
Q3 | $203K | Buy |
466
+119
| +34% | +$54K | 0.01% | 141 |
|
|
2023
Q2 | $154K | Sell |
347
-2,666
| -88% | -$1.23M | 0.01% | 147 |
|
|
2023
Q1 | $1.39M | Sell |
3,013
-5,296
| -64% | -$2.52M | 0.07% | 114 |
|
|
2022
Q4 | $4.26M | Sell |
8,309
-2,873
| -26% | -$1.46M | 0.23% | 74 |
|
|
2022
Q3 | $5.08M | Buy |
11,182
+6,424
| +135% | +$3.07M | 0.31% | 61 |
|
|
2022
Q2 | $2.3M | Buy |
+4,758
| New | +$2.35M | 0.14% | 100 |
|
|
2020
Q1 | – | Sell |
-3,906
| Closed | -$1.19M | – | 299 |
|
|
2019
Q4 | $1.19M | Sell |
3,906
-13,373
| -77% | -$3.68M | 0.13% | 172 |
|
|
2019
Q3 | $4.09M | Buy |
17,279
+7,521
| +77% | +$2.06M | 0.21% | 111 |
|
|
2019
Q2 | $2.76M | Hold |
9,758
| – | – | 0.22% | 107 |
|
|
2019
Q1 | $2.75M | Buy |
+9,758
| New | +$2.82M | 0.23% | 101 |
|
|
2018
Q4 | – | Sell |
-23,369
| Closed | -$6.31M | – | 357 |
|
|
2018
Q3 | $6.31M | Buy |
23,369
+9,895
| +73% | +$2.57M | 0.37% | 81 |
|
|
2018
Q2 | $3.25M | Sell |
13,474
-1,961
| -13% | -$454K | 0.2% | 159 |
|
|
2018
Q1 | $3.4M | Sell |
15,435
-5,460
| -26% | -$1.28M | 0.14% | 207 |
|
|
2017
Q4 | $4.77M | Buy |
+20,895
| New | +$4.45M | 0.18% | 152 |
|
|
2017
Q3 | – | Sell |
-38,780
| Closed | -$7.25M | – | 289 |
|
|
2017
Q2 | $7.25M | Buy |
38,780
+5,708
| +17% | +$1.03M | 0.32% | 109 |
|
|
2017
Q1 | $5.5M | Buy |
+33,072
| New | +$5.26M | 0.22% | 166 |
|
|
2015
Q2 | – | Sell |
-87,097
| Closed | -$13.6M | – | 209 |
|
|
2015
Q1 | $13.6M | Hold |
87,097
| – | – | 0.65% | 55 |
|
|
2014
Q4 | $11.1M | Buy |
+87,097
| New | +$10.8M | 0.5% | 66 |
|
|
2014
Q3 | – | Sell |
-158,478
| Closed | -$17.1M | – | 228 |
|
|
2014
Q2 | $17.1M | Buy |
+158,478
| New | +$16.3M | 0.75% | 43 |
|
|
2014
Q1 | – | Sell |
-78,872
| Closed | -$7.23M | – | 217 |
|
|
2013
Q4 | $7.23M | Sell |
78,872
-26,660
| -25% | -$2.37M | 0.43% | 79 |
|
|
2013
Q3 | $8.85M | Buy |
105,532
+1,712
| +2% | +$147K | 0.62% | 58 |
|
|
2013
Q2 | $8.53M | Buy |
+103,820
| New | +$7.77M | 0.64% | 50 |
|
Other funds holding ELV
Meag Munich Ergo's ELV Position: Q2 2025 in Review
Meag Munich Ergo reduced its Elevance Health (ELV) stake by 13% in Q2 2025, selling an estimated $8.76M and leaving 140,686 shares worth $54.7M. The position accounts for 1.54% of the portfolio, ranked #24.
Meag Munich Ergo first reported a position in ELV in Q2 2013 and has held it in 29 quarters since. The position peaked at $70.7M in Q1 2025. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.
- Meag Munich Ergo held 140,686 shares of Elevance Health worth $54.7M as of Q2 2025.
- Meag Munich Ergo sold 21,777 Elevance Health shares in Q2 2025, an estimated $8.76M.
- Elevance Health made up 1.54% of Meag Munich Ergo's portfolio in Q2 2025, its #24 holding.
- Meag Munich Ergo first reported a position in Elevance Health in Q2 2013 and has held it in 29 quarters since.
- Meag Munich Ergo's Elevance Health position peaked at $70.7M in Q1 2025.
- 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.
Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.